WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SF 3121

SF 3121 — Pharmacy intern provisions modifications

Overview

  • Bill number: SF 3121
  • Title: Pharmacy intern provisions modifications
  • Status: Introduced April 1, 2025; referred to Health and Human Services
  • Companion bill: HF 2997 (House)
  • Subject: Drugs and Medicine; Human Services and Human Services Department; Occupations and Professions

Purpose and intent

The bill is described as a modification to Minnesota’s pharmacy intern provisions. The available information does not include the full text or explicit changes. The title indicates an intent to revise the statutory framework governing pharmacy interns, potentially affecting requirements, oversight, or administration related to pharmacy internship programs in Minnesota.

Key provisions (as of available information)

  • The specific changes within SF 3121 are not provided in the excerpt available. Therefore, precise provisions, amendments to statutes, and new requirements cannot be detailed here.
  • The bill’s scope is suggested by its title to address pharmacy intern regulations, which typically involve:
    • Internship eligibility and enrollment criteria
    • Supervision requirements by licensed pharmacists
    • Training, experience hours, or competency benchmarks
    • Reporting, recordkeeping, and reporting of internship activities
    • Fees, licensing board administration, or oversight mechanisms
  • Until the full text is released, the exact language and substantive provisions remain to be confirmed.

Affected parties

  • Pharmacy interns and prospective interns in Minnesota
  • Supervising pharmacists and supervising pharmacists’ employers (pharmacies, hospitals, clinics)
  • Minnesota Board of Pharmacy and related state agencies administering pharmacist licensure and intern programs
  • Students in pharmacy programs and institutions providing internship opportunities
  • Patients and the public who rely on pharmacists and pharmacy services (indirectly affected through internship standards and supervision)

Procedural timeline and process

  • 2025-04-01: Introduction and first reading
  • 2025-04-01: Referred to Health and Human Services
  • Next steps (typical): The bill would move through committee hearings in the Senate Health and Human Services committee, possible amendments, and then potential floor votes. The companion HF 2997 in the House would follow parallel progress.

Related legislation

  • HF 2997 is the companion measure in the House. Reviewing HF 2997 could provide additional context or parallel provisions once its text is available.

Next steps for readers

  • Monitor the legislative record for SF 3121 for the full bill text, committee amendments, fiscal notes, and scheduled hearings.
  • Compare SF 3121 with HF 2997 once both texts are available to identify concordant changes.
  • Review the Minnesota Board of Pharmacy’s updates for any changes in internship requirements or supervision standards once the bill progresses.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.